ChemicalBook >제품 카탈로그 >R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 구조식 이미지

카스 번호:: 1065214-95-0

상품명:: R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

동의어(영문):: R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate;R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate;(R)-3,3'-Bis(3,5-dimethylphenyl)-5,5',6,6',7,7',8,8'- octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate,99%e.e.;(11bR)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1’,2’-f][1,3,2]dioxaphosphepine 4-Oxide;(11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;(11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin;Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bR)-;(11BR)-2,6-BIS(3,5-DIMETHYLPHENYL)-8,9,10,11,12,13,14,15-OCTAHYDRO-4-HYDROXY-4-OXIDE-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN,98%,(99%EE)

CBNumber:: CB42552406

분자식:: C36H37O4P

포뮬러 무게:: 564.65

MOL 파일:: 1065214-95-0.mol

속성

안전

용도

공급 업체 27

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 속성

끓는 점: 744.9±70.0 °C(Predicted)

밀도: 1.29±0.1 g/cm3(Predicted)

산도 계수 (pKa): 1.17±0.20(Predicted)

물리적 상태: 가루

색상: 흰색에서 밝은 노란색

안전

위험 및 안전 성명
위험 및 사전주의 사항 (GHS)

그림문자(GHS):

신호 어:

Warning

유해·위험 문구:

암호	유해·위험 문구	위험 등급	범주	신호 어	그림 문자	P- 코드
H315	피부에 자극을 일으킴	피부부식성 또는 자극성물질	구분 2	경고		P264, P280, P302+P352, P321,P332+P313, P362

예방조치문구:

P264	취급 후에는 손을 철저히 씻으시오.
P264	취급 후에는 손을 철저히 씻으시오.
P280	보호장갑/보호의/보안경/안면보호구를 착용하시오.
P302+P352	피부에 묻으면 다량의 물로 씻으시오.
P332+P313	피부 자극이 생기면 의학적인 조치· 조언을 구하시오.

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate C화학적 특성, 용도, 생산

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 준비 용품 및 원자재

원자재

준비 용품

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 공급 업체

글로벌( 27)공급 업체

공급자	전화	이메일	국가	제품 수	이점
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57511	58
Daicel Chiral Technologies (China)CO.,LTD	021-50460086-9 15921403865	han_yajun@dctc.daicel.com	China	6943	65
Tianjin Derchemist Science & Technology Co., Ltd.	22-58627059 13920586291	zdcomcon@126.com	China	3166	50
Bide Pharmatech Ltd.	400-1647117 15221909166	product02@bidepharm.com	China	41438	60
Shanghai Chiral bio-compound co., Ltd.	021-5068 3667/17749785980/1029026415; 17749785980	1029026415@qq.com	China	2884	58
Chengdu DingDang Pharmaceutical Co., Ltd.	028-86040038 13980902949;	market@dingdangchem.com	China	1758	55
Zhengzhou Kingorgchem Chemical Technology Co., Ltd.gy Co., Ltd.	0371-0371-65511006 18625597674	sales@kingorgchem.com	China	953	55
LaaJoo	021-60702684 18516024827	huang.jiayi@sinocompound.com	China	2654	58
Greenherbs Science and Technology Development Co., Ltd.	010-61136123	pub02@greenherbs.com.cn	China	4049	58
Shanghai Anyinuo Biomedical Technology Co., Ltd.	021-34625901	420970979@qq.com	China	5751	58

R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate 관련 검색:

(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (S)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin S- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol R-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-bi-2-naphthol R-3,3'-Bis(4-methylphenyl)-1,1'-bi-2-naphthol R-4-oxide-4-hydroxy-2,6-bis(4-Methoxyphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-4-oxide-4-hydroxy-2,6-bis[4-(trifluoroMethyl)phenyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(4-methoxyphenyl)-[1,1'-binaphthalene]-2,2'-diol (R)-3,3'-bis(4-Methoxyphenyl)-[1,1'-Binaphthalene]-2,2'-diol R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol R-3-3'-Bis(3,5-bis(methyl)phenyl)-1,1'-bi-2-naphthol R-3,3'-Bis(3,5-bis(methyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate R-3,3'-bis((3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-Bis(4-(1,1-diMethylethyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate